University of Birmingham Most healthcare facilities in many Low- and Middle-income Countries (LMICs) are unprepared to treat patients with cardiovascular diseases – despite these conditions leading to millions of people dying prematurely every year, a new study reveals. Experts analysed health survey data from eight LMICs across four World Health Organisation world regions to discover […]
Category Archives: Cardiovascular
Cardiovascular
Many low- and middle-income countries unprepared for the battle against cardiovascular disease, study finds
22
Sep
Sep
Credit: Pixabay/CC0 Public Domain Most health care facilities in many low- and middle-income countries (LMICs) are unprepared to treat patients with cardiovascular diseases—despite these conditions leading to millions of people dying prematurely every year, a new study reveals. Experts analyzed health survey data from eight LMICs across four World Health Organization world regions to discover […]
Cardiovascular
Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia
22
Sep
Sep
Purpose: Patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib are at risk of developing cardiovascular side effects (CVSEs). The molecular determinants of CVSEs have not been fully elucidated. We interrogated genetic polymorphisms in the Bruton Tyrosine Kinase (BTK) signaling pathway for their association with ibrutinib-related CVSEs. Experimental Design: We conducted a retrospective/prospective observational pharmacogenetic […]
Millions die prematurely every year from cardiovascular disease, but healthcare facilities in many developing countries are unprepared to treat patients. Published today Most healthcare facilities in many Low- and Middle-income Countries (LMICs) are unprepared to treat patients with cardiovascular diseases – despite these conditions leading to millions of people dying prematurely every year, a new […]
22
Sep
Sep
FRIDAY, Sept. 22, 2023 (HealthDay News) — Substance use has a strong association with acute cardiovascular events and maternal mortality during hospitalization for delivery, according to a study published in the October issue of JACC: Advances. Kari Evans, M.D., from the University of Arizona in Phoenix, and colleagues examined the association between substance use and […]
JAMA Network About The Study: The results of this study of 220,000 American Indian and Alaska Native patients with Medicare insurance suggest a significant burden of cardiovascular disease and cardiometabolic risk factors. These findings highlight the critical need for future efforts to prioritize the cardiovascular health of this population. Authors: Lauren A. Eberly, M.D., M.P.H., […]
While the neurological impact of a traumatic brain injury (TBI) has long been studied, new research suggests TBIs are also hard on the heart. The research team took a closer look at connections between the two organs, finding that nervous system dysfunction, neuro-inflammation, changes in the brain-gut connection and post-injury health issues may increase risk […]
Cardiovascular
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
22
Sep
Sep
September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced it has executed definitive agreements with the Icahn School of Medicine at Mount Sinai, in New York, NY, to commercialize electrocardiographic AI algorithms and assets, as well as a memorandum […]
22
Sep
Sep
The following is a summary of “One-step integrated coronary–carotid–cerebral computed tomography angiography to evaluate cardiovascular and cerebrovascular atherosclerosis,” published in the July 2023 issue of Cardiology by Liu et al. Researchers aimed to analyze the link between cardiovascular and cerebrovascular atherosclerosis with a one-step integrated coronary-carotid-cerebral computed tomography angiography (ICCC-CTA) technique, identify plaque risk factors, […]
22
Sep
Sep
NICE has set a threshold for when GPs should escalate lipid-lowering treatment to patients to reduce their cardiovascular disease (CVD) risk. It is consulting on a proposed a new NICE indicator, due for introduction in December this year, which says treatment should be escalated when non-HDL cholesterol has last been recorded as above 2.6 mmol/litre. […]